STK32C

Serine/threonine-protein kinase 32C · Q86UX6 · STK32C on Sugi Atlas →

0 patent compounds predicted against STK32C, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to STK32C by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER PHASE2/PHASE3RECRUITING
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus PHASE3UNKNOWN
Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial) PHASE2COMPLETED
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation. PHASE2ACTIVE_NOT_RECRUITING
I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers PHASE1/PHASE2NOT_YET_RECRUITING
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor PHASE2ACTIVE_NOT_RECRUITING
Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors PHASE2RECRUITING
Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus PHASE2COMPLETED
Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE) PHASE1/PHASE2NOT_YET_RECRUITING
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... PHASE2COMPLETED
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion PHASE2ACTIVE_NOT_RECRUITING
PKC412 and 5-Azacytidine PHASE1/PHASE2COMPLETED
Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis PHASE2ACTIVE_NOT_RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b PHASE1COMPLETED
Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer PHASE1COMPLETED
A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212 PHASE1COMPLETED
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
New Genes in the Carcinogenesis of Colorectal Cancer nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Exercise in Type 1 Diabetes Mellitus nanCOMPLETED
Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation nanCOMPLETED
Association Between Intakes of Protein, Calcium and Milk With Gene Expression and Linear Growth of School Aged Children nanCOMPLETED
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment nanUNKNOWN
Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period nanUNKNOWN
Protein Intake and Step Reduction in Older Adults nanCOMPLETED
NTRK 1,2,3 Rearrangements in Patients With Solid Tumors nanACTIVE_NOT_RECRUITING
A Retrospective Clinical Records Review of Patients Diagnosed With Gastrointestinal Stromal Tumour at Two Tertiary Institutes in Singapore nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a STK32C binder may also engage these)

ProteinNameSimilarity
Q8QZV4 0.995 Q8QZV4 →
Q9JJX8 0.994 Q9JJX8 →
STK32B Serine/threonine-protein kinase 32B 0.992 landscape →
RPS6KB1 Ribosomal protein S6 kinase beta-1 0.991 landscape →
MKNK1 MAP kinase-interacting serine/threonine-protein kinase 1 0.991 landscape →
Q6TJY3 0.991 Q6TJY3 →
Q8BSK8 0.991 Q8BSK8 →
PHKG2 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform 0.989 landscape →
D3ZML2 0.989 D3ZML2 →
Q68UT7 0.988 Q68UT7 →
Q7TNL3 0.988 Q7TNL3 →
Q9Z2A6 0.988 Q9Z2A6 →
Q66HE5 0.988 Q66HE5 →
Q63553 0.988 Q63553 →
O88831 0.988 O88831 →
Q641K5 0.987 Q641K5 →
Q17QV9 0.987 Q17QV9 →
Q8VBY2 0.987 Q8VBY2 →
O19111 0.986 O19111 →
Q3ULB5 0.986 Q3ULB5 →
P20689 0.986 P20689 →
Q9Z188 0.986 Q9Z188 →
Q9TUI4 0.986 Q9TUI4 →
Q4V793 0.986 Q4V793 →
Q8C078 0.986 Q8C078 →
P67998 0.986 P67998 →
Q7TNL4 0.986 Q7TNL4 →
NUAK1 NUAK family SNF1-like kinase 1 0.986 landscape →
Q0DCT8 0.986 Q0DCT8 →
CAMKK1 Calcium/calmodulin-dependent protein kinase kinase 1 0.985 landscape →